NIH panel refutes FDA’s claims of the benefits of coronavirus plasma treatment

by Raphael Stevens 1 September 2020, 23:47 199 Views

The panel said it reviewed available data on the treatment and found nothing from “well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma.”

Source: Business - cnbc.com

Band Protocol CEO says that a single Chainlink data request costs $450

China Ratchets Up Australian Trade Tensions With Barley Ban

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

NIH panel refutes FDA’s claims of the benefits of coronavirus plasma treatment

Band Protocol CEO says that a single Chainlink data request costs $450

China Ratchets Up Australian Trade Tensions With Barley Ban

ITALIAN LANGUAGE

ENGLISH LANGUAGE